Genea Biocells

Human Stem Cell Model of Muscular Dystrophy (FSHD) – qPCR

Chemical Genomics

Our team at Genea Biocells was one of the first to systematically use high-throughput screening to modulate pluripotency maintenance and differentiation of stem cells. We developed a monolayer culture method for human pluripotent stem cells in 2008 to enable efficient high-content imaging – our primary technology for drug screening, optimization of culture processes and aspects of quality control testing.

Our medicinal chemistry platform blends modern drug discovery and stem cell science concepts:

Stem Cell Biology

  • ‘Traditional’ and new targets, pathways, cellular processes
  • Validated and emerging agents
  • Diverse activity, selectivity, etiology, & pharmacology
  • Characterization data for each compound
  • Evolving, evidence-based approach

Medical Chemistry Optimization

  • Drug-like compounds
  • Favorable solubility, cellular permeability, stability, & safety profile
  • Entry to optimization and internal discovery
  • Hit follow-up, structure-activity relationship studies, de-risking, & reprofiling
  • IP considerations

Leave a Reply

Your email address will not be published. Required fields are marked *